Animal & Veterinary
CVM Working to Address Shortage of Injectable Iron Dextran
December 3, 2007
The below CVM Update was revised on December 12, 2007 to include changes in the first and third paragraphs.
The Center for Veterinary Medicine (CVM) is aware that there is a likelihood of a shortage of the injectable drug, iron dextran, for the prevention and treatment of iron deficiency in baby pigs. CVM considers iron dextran a medically necessary drug and recognizes that a shortage could result in undue animal suffering and disruption in the swine industry. In order to address and alleviate the inadequate supply, CVM is not objecting to Bimeda Inc. of Lehigh, Iowa and Vetoquinol Inc. of Quebec, Canada temporarily importing and distributing an injectable 200 mg/ml iron dextran product in the United States (U.S.) from Bimeda MTC Animal Health Inc. of Cambridge, Ontario, Canada through the end of May 2008 or until an adequate U.S. domestically manufactured supply is available.
CVM is committed to working with veterinarians to supply animal drugs for legitimate medical needs and will consider and evaluate other requests from other manufacturers of the injectable iron dextran product, as needed.
See the below letters for additional information.